June 5, 2019 / 9:38 PM / 10 days ago

Insys to pay $225 mln, unit to plead guilty to settle U.S. opioid charges

June 5 (Reuters) - Insys Therapeutics Inc agreed to pay $225 million and an operating unit agreed to plead guilty to five mail fraud counts to settle criminal and civil probes into its marketing of opioids, the U.S. Department of Justice said on Wednesday.

The probes stemmed from Insys’ payment of kickbacks and other illegal marketing practices related to its cancer pain drug Subsys, a fentanyl spray that is a powerful, highly addictive opioid painkiller, the Justice Department said. (Reporting by Jonathan Stempel in New York; editing by Bill Berkrot)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below